PMC2018 Mobile Header 300x76

Advancements in Basal Insulin: Tailoring Treatment to Patient Needs

Type: Accredited Symposia
Thursday May 10
6:00pm to 7:00pm
Location: Symposia B

  • Description

    Basal insulin remains one of the most effective treatments for type 2 diabetes, resulting from its high potency and lack of a dose ceiling. But, as patients and healthcare providers will affirm, it has long been a balancing act between the highs and lows. Over the course of this session, participants will explore the key barriers to insulin therapy, the latest basal insulin options, and strategies to individualize insulin therapy in type 2 diabetes. Furthermore, participants will use case-based discussion alongside a workbook to apply new knowledge, and reflect on how the latest insulin options can be integrated into clinical practice to improve patient care.

    Learning Objectives
    • Recognize the role of basal insulin therapy in the T2DM treatment continuum.
    • Identify and overcome barriers to insulin initiation and optimization from the patient and physician perspective, including hypoglycemia.
    • Differentiate basal insulin options, with a focus on the newer basal insulins.
    • Individualize basal insulin treatment based on patient characteristics and insulin profiles.

    Accreditation Statement:
    This Group Learning program has been reviewed by the College of Family Physicians of Canada and is awaiting final certification by the College’s Ontario Chapter.

    Industry Support
    This program was supported in part by an educational grant from Novo Nordisk.
  • Speakers